Serum miR-224 reflects stage of hepatocellular carcinoma and predicts survival

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Zhuang, Li Ping ^a,b   Meng, Zhi Qiang ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 224; SORAFENIB; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATITIS B; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER INJURY; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERCUTANEOUS RADIOFREQUENCY ABLATION; PORTAL VEIN THROMBOSIS; PORTAL VEIN TUMOR THROMBOSIS; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGED; BLOOD; CARCINOMA, HEPATOCELLULAR; COHORT ANALYSIS; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 84922366984     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/731781     Document Type: Article

References (37)

1. D. P. Bartel, "MicroRNAs: genomics, biogensis, mechanism and function", Cell, vol. 116, pp. 281-297, 2004.
2. J. Krol, I. Loedige, and W. Filipowicz, "The widespread regulation of microRNA biogenesis, function and decay", Nature Reviews Genetics, vol. 11, no. 9, pp. 597-610, 2010.
3. G. A. Calin, C. Sevignani, C. D. Dumitru et al., "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers", Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999-3004, 2004.
4. A. Esquela-Kerscher and F. J. Slack, "Oncomirs-microRNAs with a role in cancer", Nature Reviews Cancer, vol. 6, no. 4, pp. 259-269, 2006.
5. S. Gounaris-Shannon and T. Chevassut, "The role of miRNA in haematological malignancy", Bone Marrow Research, vol. 2013, Article ID 269107, 12 pages, 2013.
6. K. John, J. Wu, B. W. Lee, and C. S. Farah, "MicroRNAs head and neck cancer", International Journal of Dentistry, vol. 2013, Article ID 650218, 12 pages, 2013.
7. L. Mulrane, S. F. McGee, W. M. Gallagher, and D. P. O'Connor, "miRNA dysregulation in breast cancer", Cancer Research, vol. 73, no. 22, pp. 6554-6562, 2013.
8. X. W. Wang, N. H. H. Heegaard, and H. Orum, "MicroRNAs in liver disease", Gastroenterology, vol. 142, no. 7, pp. 1431-1443, 2012.
9. J. Lu, G. Getz, E. A. Miska et al., "MicroRNA expression profiles classify human cancers", Nature, vol. 435, no. 7043, pp. 834-838, 2005.
10. S. Volinia, G. A. Calin, C.-G. Liu et al., "A microRNA expression signature of human solid tumors defines cancer gene targets", Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
11. X. Chen, Y. Ba, L. Ma et al., "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases", Cell Research, vol. 18, no. 10, pp. 997-1006, 2008.
12. Y. Wang, H. C. Toh, P. Chow et al., "MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms", The FASEB Journal, vol. 26, no. 7, pp. 3032-3041, 2012.
13. P.-J. Chen, S.-H. Yeh, W.-H. Liu et al., "Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis", Hepatology, vol. 56, no. 2, pp. 632-643, 2012.
14. P. Gao, C. C.-L. Wong, E. K.-K. Tung, J. M.-F. Lee, C.-M. Wong, and I. O.-L. Ng, "Deregulation of microRNA expression occurs earlyand accumulates in earlystages of HBV-associated multistep hepatocarcinogenesis", Journal of Hepatology, vol. 54, no. 6, pp. 1177-1184, 2011.
15. Y. Zhang, S. Takahashi, A. Tasaka, T. Yoshima, H. Ochi, and K. Chayama, "Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma", Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 565-575, 2013.
16. K. Yuki, S. Hirohashi, M. Sakamoto, T. Kanai, and Y. Shimosato, "Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases", Cancer, vol. 66, no. 10, pp. 2174-2179, 1990.
17. S. Cheng, M. Wu, H. Chen et al., "Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein", Hepato-Gastroenterology, vol. 54, no 74, pp 499-502, 2007
18. G.-Y. Chau, W.-Y. Lui, K.-L. King, and C.-W. Wu, "Evaluation of effect of hemihepatic vascular occlusion and the pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function", World Journal of Surgery, vol. 29, no. 11, pp. 1374-1383, 2005.
19. J. Bruix and M. Sherman, "Management of hepatocellular carcinoma: an update", Hepatology, vol. 53, no. 3, pp. 1020-1022, 2011.
20. E. Giovannetti, N. Funel, G. J. Peters et al., "MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity", Cancer Research, vol. 70, no. 11, pp. 4528-4538, 2010.
21. Z.-Y. Tang, "Hepatocellular carcinoma-cause, treatment and metastasis", World Journal of Gastroenterology, vol. 7, no. 4, pp. 445-454, 2001.
22. C. K. Lindsay, C. C. Sinha, and U. P. Thorgeirsson, "Morphological study of vascular dissemination in a metastatic hepatocellular carcinoma model in the monkey", Hematology, vol. 26, no. 5, pp. 1209-1215, 1997.
23. M. Mitsunobu, A. Toyosaka, T. Oriyama, E. Okamoto, and N. Nakao, "Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel", Clinical & Experimental Metastasis, vol. 14, no. 6, pp. 520-529, 1996.
24. J. Haybaeck, N. Zeller, and M. Heikenwalder, "The parallel universe: microRNAs and their role in chronic hepatitis, liver tissuedamageand hepatocarcinogenesis", Swiss Medical Weekly, vol. 141, Article ID w13287, 2011.
25. S. Liu, W. Guo, J. Shi et al., "MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma", Journal of Hepatology, vol. 56, no. 2, pp. 389-396, 2012.
26. C.-M. Wong, C. C.-L. Wong, J. M.-F. Lee, D. N.-Y. Fan, S. L.-K. Au, and I. O.-L. Ng, "Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis", Hepatology, vol. 55, no. 5, pp. 1453-1461, 2012.
27. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., "Circulating microRNAs as stable blood-based markers for cancer detection", Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513-10518, 2008.
28. H. Schwarzenbach, N. Nishida, G. A. Calin, and K. Pantel, "Clinical relevance of circulating cell-free microRNAs in cancer", Nature Reviews Clinical Oncology, vol. 11, no. 3, pp. 145-156, 2014.
29. P. Friedl and S. Alexander, "Cancer invasion and the microenvironment: plasticity and reciprocity", Cell, vol. 147, no. 5, pp. 992-1009, 2011.
30. F. Balkwill, K. A. Charles, and A. Mantovani, "Smoldering and polarized inflammation in the initiation and promotion of malignant disease", Cancer Cell, vol. 7, no. 3, pp. 211-217, 2005.
31. P. Yang, Q.-J. Li, Y. Feng et al., "TGF-/3-miR-34a-CCL22 signaling-induced treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma", Cancer Cell, vol. 22, no. 3, pp. 291-303, 2012.
32. D.-X. Lin, Q.-Y. Zhang, X. Li, Q.-W. Ye, F. Lin, and L.-L. Li, "An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus", Journal of Cancer Research and Clinical Oncology, vol. 137, no. 1, pp. 139-149, 2011.
33. D. Takizawa, S. Kakizaki, N. Sohara et al., "Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis", Digestive Diseases and Sciences, vol. 52, no. 11, pp. 3290-3295, 2007.
34. S.-N. Shen, L.-F. Wang, Y.-F. Jia, Y.-Q. Hao, L. Zhang, and H. Wang, "Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer", Diagnostic Pathology, vol. 8, no. 1, Article69, 2013.
35. J. Boguslawska, A. Wojcicka, A. Piekielko-Witkowska, A. Master, and A. Nauman, "MiR-224 targets the 3'UTR of type 15'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer", PLoS ONE, vol. 6, no. 9, Article ID e24541, 2011.
36. K. Mavridis, K. Stravodimos, and A. Scorilas, "Downregulation and prognostic performance of microRNA 224 expression in prostate cancer", Clinical Chemistry, vol. 59, no. 1, pp. 261-269, 2013.
37. C. Scisciani, S. Vossio, F. Guerrieri et al., "Transcriptional regulation of miR-224 upregulated in human HCCs by NF/cB inflammatory pathways", Journal of Hepatology, vol. 56, no. 4, pp. 855-861, 2012.